Building Racial Equity into the Drug Development System

December 7, 2020

This webinar was the first of a two-part virtual forum examining racial equity in the drug development system, from research all the way through to access.

The conversation specifically explored racial inequities in drug investment and research and identified new directions for the future.

Our speakers

Medical Director for Pharmacy in Northern California, The Permanente Medical Group

Co-Founder, Co-Executive Director, I-MAK

Assistant professor of infectious diseases and pediatrics, National School of Tropical Medicine, Baylor College of Medicine

Partner, Kapor Capital

Stanford Medicine, Professor of Medicine Former NIH Chief Scientific Officer for Scientific Workforce Diversity

9:30 - 9:40 a.m.	Opening remarks
9:40 - 10:00 a.m.	Keynote: A framework for understanding structural racism in the medicines system
10- 10:55 a.m.	Panel: In whose interests? Building racial equity into pharmaceutical investment and funding
10:55 - 11:00 a.m.	Closing remarks